Aardvark Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-18.1M | $-18.2M | $109.0K | $439.0K |
| FY2025 | $-54.2M | $-54.3M | $95.0K | $3.9M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-18.1M | $-18.2M | $109.0K | $439.0K |
| FY2025 | $-54.2M | $-54.3M | $95.0K | $3.9M |